Uncategorized
Microban® backs antimicrobial additives as a scientifically supported strategy for cleaner building materials
May 13, 2021
Microban® International – the global leader in antimicrobial additives and odor control solutions – has released a statement discrediting unwarranted claims about the safety and efficacy of antimicrobial technologies. This statement is intended to ensure that the public, consumers, and other stakeholders are equipped to make fully informed decisions, based on scientific reasoning. Making...Read More
Speeding up cell culture workflows with INTEGRA’s serological pipettor
May 6, 2021
Anion dysregulation is seen in numerous diseases, from cystic fibrosis and chronic pain, to autism and cancer. Researchers at the University of Dallas are investigating anion transport in vivo, developing novel tools to help analyze the effects of both normal and...Read More
June Medical honoured with prestigious Queen’s Award for Enterprise
April 29, 2021
June Medical is one of 48 organisations to be recognised for their excellence in innovation in this year’s Queen’s Awards for Enterprise. Now in its 55th year, the Queen’s Awards for Enterprise are the most prestigious business awards in the country...Read More
Microban shines a light on the cracks in TiO2
April 28, 2021
More and more interest has arisen in recent years regarding the use of titanium dioxide (TiO2) as an antimicrobial additive in ceramics. A report from the International Agency for Research on Cancer1 recently classified TiO2 as ‘possibly carcinogenic to humans’ by inhalation and similarly, the...Read More
Redefining stem cell research with INTEGRA’s VIAFLO pipettes
April 15, 2021
INTEGRA Biosciences’ VIAFLO electronic pipettes are helping denovoMATRIX in Dresden, Germany, to produce modular, biomimetic coatings for cell culture plasticware that can be tailored to recreate a large variety of conditions for testing adherent cell cultures. Chief Scientific Officer...Read More
Mosaic Surgical and Key2Compliance collaborate to support medical device distribution in the UK following Brexit
April 14, 2021
UK-based regulatory consultancy company Mosaic Surgical has formed a partnership with Key2Compliance – a Swedish provider of customised business solutions in the life sciences arena – to overcome some of the challenges associated with the UK leaving the European...Read More
Sartorius Launches the Octet® R Series for Label-Free, Real-Time Molecular Analysis, Designed with Versatility and Futureproofing in Mind
March 29, 2021
Three new bio-layer interferometry (BLI) systems: Octet® R2 with 2-channels, Octet® R4 with 4-channels and Octet® R8 with 8-channels Field upgradeable to the higher channel system, providing the flexibility to expand based on throughput needs and budget Rapidly determine affinity, kinetics, and...Read More
JUNE Medical rapidly expands supply of Galaxy retractors across USA
March 25, 2021
JUNE Medical Group is thrilled to announce that its revolutionary, self-retaining Galaxy II™ surgical retractors are now available across the USA. Following the creation of a successful distribution partnership with Medworks to supply the Galaxy range to urology and gynecology surgery markets across several states, JUNE Medical is now...Read More
Microban and Everbrite partner to offer new antimicrobial coating that fights corrosion and bacteria
March 24, 2021
Microban International and Everbrite have joined forces to develop CrobialCoat™, an innovative coating that combines Microban antimicrobial technology and Everbrite ProtectaClear® to provide invisible surface protection with visible cleanliness. CrobialCoat is a durable, clear and highly adhesive coating designed to provide long-lasting product protection from rust, salt damage, tarnish, corrosion and oxidation on most surfaces, with the added benefit...Read More
INTEGRA’S ASSIST PLUS aids the battle against antibiotic resistance
March 18, 2021
INTEGRA Biosciences’ ASSIST PLUS pipetting robot and VOYAGER adjustable tip spacing pipettes are proving invaluable to scientists at Southmead Hospital in Bristol, helping the development of novel antibiotics against resistant strains of Gram-negative bacteria. Senior research scientist Adrianna Olejniczak...Read More